Grant: Planning and Dissemination Grant - Institute Community Support
McGill University
$8,825.00
Montreal International Symposium on Angiogenesis and Metastasis (MISAM) 2016
FY 2015-16
Summary
Cancer represents a major and frightening personal and medical challenge, but changes are on the horizon. The MISAM 2016 meeting is designed to convey the sense of this emerging momentum and its major constituents, as well as the still unexplored opportunities. Recent technological advances in genomics led, in less than a decade, to an explosion in molecular epigenetics in cancer research. Epigenetics refers to the science of structural changes superimposed on the pre-existing, hard wired genetic code of normal and cancer cells. These changes are often critical to the onset of cancer and metastasis and are potentially reversible, which is of tremendous biological and medical interest. Epigenetics encompasses biochemical modifications of DNA itself, histone proteins on which DNA rests and processes that alter their functional output - RNA transcripts that alter basic cellular activities and become the driving force in oncogenic transformation. Indeed, oncoprotein and tumour suppressor protein expression in various types of cancers is often regulated epigenetically. This spectacular progress revealed the unexpected diversity and multiplicity of cancers affected and the driving mutations and pathways affecting the enzymes responsible for such modifications. Indeed, these fascinating studies are on the verge of being assigned more functional and biological meaning, and to enter therapeutic translation. Thus, this is the time to catalyze such changes and appraise this dynamic field. MISAM 2016 is designed to do just that. The meeting will bring together experts in cancer, epigenetics and molecular pathology as well as investigators studying key biological processes and developing therapeutics.
Department
Program
Planning and Dissemination Grant - Institute Community Support
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
334646
Name
Beauchemin Nicole
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Planning and Dissemination - ICR
Projecttitle
Montreal International Symposium on Angiogenesis and Metastasis (MISAM) 2016
Programtype2
Miscellaneous Programs
Orgnameinp2
McGill University
Cihramount2
$8,825
Cihrequipment2
$0
Programname2
Planning and Dissemination Grant - Institute Community Support
Keyworddelim
Basic Mechanisms; Cancer; Drug Discovery; Epigenetic; Metastasis; Oncology; Scientific Meeting
Abstract
Cancer represents a major and frightening personal and medical challenge, but changes are on the horizon. The MISAM 2016 meeting is designed to convey the sense of this emerging momentum and its major constituents, as well as the still unexplored opportunities. Recent technological advances in genomics led, in less than a decade, to an explosion in molecular epigenetics in cancer research. Epigenetics refers to the science of structural changes superimposed on the pre-existing, hard wired genetic code of normal and cancer cells. These changes are often critical to the onset of cancer and metastasis and are potentially reversible, which is of tremendous biological and medical interest. Epigenetics encompasses biochemical modifications of DNA itself, histone proteins on which DNA rests and processes that alter their functional output - RNA transcripts that alter basic cellular activities and become the driving force in oncogenic transformation. Indeed, oncoprotein and tumour suppressor protein expression in various types of cancers is often regulated epigenetically. This spectacular progress revealed the unexpected diversity and multiplicity of cancers affected and the driving mutations and pathways affecting the enzymes responsible for such modifications. Indeed, these fascinating studies are on the verge of being assigned more functional and biological meaning, and to enter therapeutic translation. Thus, this is the time to catalyze such changes and appraise this dynamic field. MISAM 2016 is designed to do just that. The meeting will bring together experts in cancer, epigenetics and molecular pathology as well as investigators studying key biological processes and developing therapeutics.
Competitiondate
201508
Approvedterm2
1 yr 0 mth
Pinamesdelim
Beauchemin, Nicole
Approvedterm
1 an 0 mois
Cihrcontribution2
Inst of Cancer Research~ $8,825~ $0~